TRIAL UPDATE: 15 July 2025 The TROG 20.01 CHEST-RT trial is set to add to the evidence about whether radiation therapy could be a safe and useful addition in the management of an aggressive form of lung cancer, as outlined in a newly published paper. Congratulations to trial chairs
TRIAL UPDATE: 8 July 2025 The TROG 19.06 DECREASE trial into advanced prostate cancer has reached a significant milestone with recruitment of the final participant in late June, bringing total recruitment to 70 participants. Congratulations to trial chairs Prof Shankar Siva and Prof Arun Azad and all involved in
LATEST NEWS: 26 June 2025 He may be 76 years old and have survived cancer, but that’s certainly not slowing down Geoff Zipper, who will set off on the gruelling 96km Kokoda Trek next week for the fifth time, devoting his efforts to supporting TROG’S work. Geoff, known as
LATEST NEWS: 24 JUNE 2025 The latest annual report from TROG Cancer Research showcases a year of impactful research, global collaboration and initiatives to support equity in radiation therapy clinical trials. Highlights in the 2024 Annual Research Report include: TROG President A/Prof Puma Sundaresan highlighted the organisation’s robust financial
LATEST NEWS: 11 JUNE 2025 New findings from a trial into treating a common form of skin cancer – cutaneous squamous cell carcinoma (CSCC) – could be a game-changer for many people at high risk of recurrence of disease. Lead investigator Prof Danny Rischin presented results of primary analysis
LATEST NEWS: 10 JUNE 2025 A trial of a novel radiation therapy approach to treat advanced lung cancer is set to enrol its first participants early next year, after investigators welcomed a $1.5 million Medical Research Future Fund grant. The Primary Radiotherapy in Metastatic Lung (PRIME-Lung) study – sponsored
LATEST NEWS: 5 JUNE 2025 The Alan Walker Cancer Care Centre (AWCCC) in the Northern Territory recently recruited the 300th participant to the Australian Particle Therapy Clinical Quality Registry (ASPIRE), in a milestone achievement amid a push to expand clinical research participation in rural and remote locations. The ASPIRE
LATEST NEWS: 27 May 2025 A team of five intrepid trekkers are getting ready to hike the arduous 96 km Kokoda Trail next month to raise funds for TROG Cancer Research, driven by the desire to honour Australia’s WWII soldiers while making a difference to the lives of those
LATEST NEWS: 27 MAY 2025 TROG members and staff marked Clinical Trials Day 2025 on 20 May with a range of colourful celebrations, highlighting the crucial value of clinical trials to advance medical science, including in the area of radiation therapy. The annual day is an opportunity to recognise
MEDIA RELEASE: 20 MAY 2025 The world-leading impact of a Newcastle-based cancer research organisation is in the spotlight this International Clinical Trials Day (Tuesday 20 May), after funding was granted for groundbreaking new research projects. The Trans Tasman Radiation Oncology Group –TROG Cancer Research – has been leading radiation
For over 30 years, Trans-Tasman Radiation Oncology Group has been dedicated to improving the way radiation medicine is delivered to cancer patients with ongoing scientific research, clinical trials, and cutting-edge technology.
Latest News
Keep up to date with TROG news, subscribe to our community newsletter.
ABN: 45 132 672 292
